OraSure Technologies | OSUR - Current Assets


OraSure Technologies reported $222.94M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Agilent USD 4.69B 70M Jun/2026
AngioDynamics USD 161.35M 4.69M Sep/2025
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Bio Techne USD 744.4M 56.35M Jun/2026
Bio-Rad Laboratories USD 3.08B 58.1M Sep/2026
Bruker USD 2.16B 67.9M Sep/2026
Cerus USD 174.38M 7.26M Dec/2025
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
Dentsply International USD 1.98B 50M Sep/2026
Dexcom USD 3.92B 170.6M Sep/2026
Illumina USD 3.04B 201M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Mettler Toledo International USD 1.38B 28.79M Sep/2026
Myriad Genetics USD 289M 23.8M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Quidel USD 1.45B 69.4M Sep/2026
Repligen USD 1.24B 41.43M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
STAAR Surgical USD 353.43M 11.08M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Trinity Biotech USD 31.36M 4.54M Mar/2026
Waters USD 3.9B 186M Jun/2026